Short Interest in Rock Creek Pharmaceuticals, Inc. (OTCMKTS:RCPIQ) Rises By 2,500.0%

Rock Creek Pharmaceuticals, Inc. (OTCMKTS:RCPIQ) was the recipient of a large increase in short interest in the month of May. As of May 28th, there was short interest totalling 5,200 shares, an increase of 2,500.0% from the May 13th total of 200 shares. Based on an average daily volume of 631,200 shares, the short-interest ratio is presently 0.0 days.

Shares of RCPIQ remained flat at $$0.00 during trading hours on Friday. 2,403,888 shares of the company traded hands, compared to its average volume of 915,528. Rock Creek Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.02.

About Rock Creek Pharmaceuticals

Rock Creek Pharmaceuticals, Inc, a pharmaceutical development company, focuses on the discovery, development, and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its lead compound is Anatabine citrate, a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics, with a mechanism of action distinct from other anti-inflammatory drugs available, such as biologics, steroids, and non-steroidal anti-inflammatories.

Further Reading: Market Timing – The Benefits and the Danger

Receive News & Ratings for Rock Creek Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rock Creek Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.